Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-01 6:38 pm Unchanged | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 13,956,685 18.64% | 0 (Unchanged) | View |
| 2024-02-14 8:28 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 5,555,568 9.99% | 1,324,947 (+31.32%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm Biocapital Advisors LP | 5,304,313 9.99% | 2,993,615 (+129.55%) | View |
| 2024-02-14 4:05 pm Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | COMMODORE CAPITAL LP | 1,924,074 3.7% | -96,092 (-4.76%) | View |
| 2024-02-14 09:22 am Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,302,094 (Position Closed) | View |
| 2024-02-14 09:01 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital LP | 5,378,997 9.9% | 2,066,023 (+62.36%) | View |
| 2024-02-13 5:17 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | VANGUARD GROUP INC | 3,000,948 5.71% | 885,954 (+41.89%) | View |
| 2024-01-29 4:53 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | PERCEPTIVE ADVISORS LLC | 4,022,066 6.7% | 4,022,066 (New Position) | View |
| 2024-01-29 3:26 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BlackRock Inc. BLK | 3,426,450 6.5% | 664,894 (+24.08%) | View |
| 2024-01-24 5:12 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 13,956,685 19.43% | 1,192,292 (+9.34%) | View |
| 2024-01-24 08:13 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | STATE STREET CORP STT | 2,708,383 5.15% | 2,708,383 (New Position) | View |
| 2024-01-10 08:53 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | FMR LLC | 7,625,542 14.501% | 7,625,542 (New Position) | View |
| 2023-12-08 4:17 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Opportunities Fund L.P. | 2,823,921 5.2% | 2,823,921 (New Position) | View |
| 2023-11-03 4:30 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 12,764,393 19.99% | 3,571,579 (+38.85%) | View |
| 2023-06-14 4:15 pm Unchanged | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Atlas Venture Fund VII L P | 0 0% | 0 (Unchanged) | View |
| 2023-05-11 4:26 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm Biocapital Advisors LP | 2,310,698 5.4% | 419,531 (+22.18%) | View |
| 2023-02-14 4:59 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm Biocapital Advisors LP | 1,891,167 4.7% | 682,116 (+56.42%) | View |
| 2023-02-14 4:30 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 4,230,621 9.99% | 2,025,353 (+91.84%) | View |
| 2023-02-14 3:05 pm Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Cormorant Asset Management LP | 1,100,000 2.73% | -336,322 (-23.42%) | View |
| 2023-02-14 2:23 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover GP I LLC | 983,610 2.4% | 983,610 (New Position) | View |